Fate and state transitions during human blood vessel organoid development
- PMID: 40250419
- DOI: 10.1016/j.cell.2025.03.037
Fate and state transitions during human blood vessel organoid development
Abstract
Human blood vessel organoids (hBVOs) have emerged as a system to model human vascular development and disease. Here, we use single-cell multi-omics together with genetic and signaling pathway perturbations to reconstruct hBVO development. Mesodermal progenitors bifurcate into endothelial and mural fates in vitro, and xenografted BVOs acquire definitive arteriovenous endothelial cell specification. We infer a gene regulatory network and use single-cell genetic perturbations to identify transcription factors (TFs) and receptors involved in cell fate specification, including a role for MECOM in endothelial and mural specification. We assess the potential of BVOs to generate organotypic states, identify TFs lacking expression in hBVOs, and find that induced LEF1 overexpression increases brain vasculature specificity. Finally, we map vascular disease-associated genes to hBVO cell states and analyze an hBVO model of diabetes. Altogether, we provide a comprehensive cell state atlas of hBVO development and illuminate the power and limitation of hBVOs for translational research.
Keywords: arteriovenous specification; human blood vessel organoid; human development; organoid cell atlas; single-cell genomics; single-cell perturbation screen.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.M.P. is one of the authors of the patent application US20200199541A1 relating to blood vessel organoid generation. Furthermore, J.M.P. is the founder, shareholder, and chairman of the scientific advisory board of Angios Biotech, a company establishing BVOs for drug testing and vascular transplants.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources